ResMed Inc.

211.50+4.01+1.93%Vol 1.16M1Y Perf -15.64%
Jun 24th, 2022 16:00 DELAYED
BID210.45 ASK212.18
Open210.85 Previous Close207.49
Pre-Market- After-Market211.50
 - -  - -%
Target Price
256.22 
Analyst Rating
Moderate Buy 1.58
Potential %
21.14 
Finscreener Ranking
★+     43.67
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★+     44.59
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     65.91
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★+     37.25
Price Range Ratio 52W %
19.74 
Earnings Rating
Strong Sell
Market Cap30.94B 
Earnings Date
4th Aug 2022
Alpha0.02 Standard Deviation0.08
Beta0.45 

Today's Price Range

208.20211.58

52W Range

189.40301.34

5 Year PE Ratio Range

22.7069.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
7.05%
1 Month
8.24%
3 Months
-12.00%
6 Months
-18.28%
1 Year
-15.64%
3 Years
74.55%
5 Years
169.63%
10 Years
644.03%

TickerPriceChg.Chg.%
RMD211.504.01001.93
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
1.10
2.60
0.20
0.25
173.40
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
56.30
27.70
33.20
23.00
21.95
RevenueValueIndustryS&P 500US Markets
3.54B
24.20
9.86
11.00
DividendsValueIndustryS&P 500US Markets
0.85
1.68
3.12
4.36
Payout ratio48.00
Earnings HistoryEstimateReportedSurprise %
Q03 20221.441.32-8.33
Q02 20221.471.470.00
Q01 20221.351.5111.85
Q04 20211.251.358.00
Q03 20211.221.306.56
Q02 20211.221.4115.57
Q01 20210.981.2729.59
Q04 20200.971.3337.11
Earnings Per EndEstimateRevision %Trend
6/2022 QR1.49-12.87Negative
6/2022 FY5.74-6.06Negative
9/2022 QR1.52-10.06Negative
6/2023 FY6.66-5.13Negative
Next Report Date4th Aug 2022
Estimated EPS Next Report1.49
Estimates Count3
EPS Growth Next 5 Years %15.70
Volume Overview
Volume1.16M
Shares Outstanding146.28K
Shares Float129.59M
Trades Count20.47K
Dollar Volume243.48M
Avg. Volume696.71K
Avg. Weekly Volume920.34K
Avg. Monthly Volume598.70K
Avg. Quarterly Volume571.10K

ResMed Inc. (NYSE: RMD) stock closed at 211.5 per share at the end of the most recent trading day (a 1.93% change compared to the prior day closing price) with a volume of 1.16M shares and market capitalization of 30.94B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7970 people. ResMed Inc. CEO is Michael J. Farrell.

The one-year performance of ResMed Inc. stock is -15.64%, while year-to-date (YTD) performance is -18.8%. RMD stock has a five-year performance of 169.63%. Its 52-week range is between 189.4 and 301.34, which gives RMD stock a 52-week price range ratio of 19.74%

ResMed Inc. currently has a PE ratio of 37.20, a price-to-book (PB) ratio of 8.81, a price-to-sale (PS) ratio of 8.17, a price to cashflow ratio of 58.30, a PEG ratio of 2.32, a ROA of 16.53%, a ROC of 20.28% and a ROE of 26.19%. The company’s profit margin is 21.95%, its EBITDA margin is 33.20%, and its revenue ttm is $3.54 Billion , which makes it $24.20 revenue per share.

Of the last four earnings reports from ResMed Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.49 for the next earnings report. ResMed Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for ResMed Inc. is Moderate Buy (1.58), with a target price of $256.22, which is +21.14% compared to the current price. The earnings rating for ResMed Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ResMed Inc. has a dividend yield of 0.85% with a dividend per share of $1.68 and a payout ratio of 48.00%.

ResMed Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 15.37, ATR14 : 6.00, CCI20 : 83.16, Chaikin Money Flow : 0.15, MACD : -0.57, Money Flow Index : 70.24, ROC : -1.40, RSI : 56.79, STOCH (14,3) : 83.45, STOCH RSI : 1.00, UO : 57.05, Williams %R : -16.55), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ResMed Inc. in the last 12-months were: Brett A. Sandercock (Sold 0 shares of value $-1 775 311 ), Brett A. Sandercock (Sold 40 736 shares of value $10 821 053 ), Carol J. Burt (Sold 2 687 shares of value $711 440 ), David B. Pendarvis (Sold 0 shares of value $-199 824 ), David B. Pendarvis (Sold 27 220 shares of value $6 960 576 ), James R. Hollingshead (Sold 12 000 shares of value $3 179 350 ), Michael J. Farrell (Sold 0 shares of value $-2 294 516 ), Michael J. Farrell (Sold 39 725 shares of value $9 110 923 ), Rajwant Sodhi (Sold 4 500 shares of value $1 204 695 ), Robert Andrew Douglas (Sold 0 shares of value $-6 988 800 ), Robert Andrew Douglas (Sold 120 000 shares of value $31 178 640 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (66.67 %)
8 (66.67 %)
8 (66.67 %)
Moderate Buy
1 (8.33 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (25.00 %)
4 (33.33 %)
4 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.58
Moderate Buy
1.67
Moderate Buy
1.67

ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

CEO: Michael J. Farrell

Telephone: +1 858 836-5000

Address: 9001 Spectrum Center Boulevard, San Diego 92123, CA, US

Number of employees: 7 970

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

63%37%

Bearish Bullish

60%40%

TipRanks News for RMD

Sat, 30 Apr 2022 12:10 GMT Analysts Offer Insights on Healthcare Companies: Laboratory (LH), Resmed (RMD) and Anthem (ANTM)

- TipRanks. All rights reserved.

Fri, 29 Apr 2022 12:48 GMT Resmed (RMD) Receives a Hold from RBC Capital

- TipRanks. All rights reserved.

Fri, 29 Apr 2022 12:47 GMT Resmed (RMD) Receives a Buy from KeyBanc

- TipRanks. All rights reserved.

Fri, 29 Apr 2022 09:55 GMT Resmed (RMD) Receives a Hold from Needham

- TipRanks. All rights reserved.

Thu, 24 Mar 2022 12:05 GMT Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Immatics (IMTX)

- TipRanks. All rights reserved.

Thu, 13 Jan 2022 12:42 GMT Positive Report for Resmed (RMD) from CLSA

- TipRanks. All rights reserved.

Thu, 13 Jan 2022 12:35 GMT Analysts Conflicted on These Healthcare Names: Resmed (RMD), Rigel (RIGL) and Enanta Pharmaceuticals (ENTA)

- TipRanks. All rights reserved.

News

Stocktwits